Interestingly, the protein abundance and nuclear localization of PIAS1 were found to predict positive outcome in a cohort of breast cancer patients suggesting potential utility of these two PIAS1 parameters as prognostic biomarkers in breast cancer [59]. This evidence concerns the gene PIAS1 and breast carcinoma.